Respiratory viral infections in primary immune deficiencies: Significance and relevance to clinical outcome in a single BMT unit

Bone Marrow Transplantation

Volumn 26, Issue 10, 2000, Pages 1097-1102

  Crooks, B N A ^a   Taylor, C E ^a   Turner, A J L ^a   Osman, H K E ^b   Abinun, M ^a   Flood, T J ^a   Cant, A J ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Bone marrow transplantation; Budesonide; Immunoglobulin; Respiratory viruses; Ribavirin; Severe combined immunodeficiency

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTIVIRUS AGENT; BUDESONIDE; BUSULFAN; CD2 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; RIBAVIRIN; SANDGLOBULIN; THIOTEPA; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CHILD; CHILDHOOD MORTALITY; COMBINED IMMUNODEFICIENCY; COMMON COLD; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HOSPITAL ADMISSION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MORBIDITY; NASOPHARYNX; NEWBORN; PARAMYXOVIRUS; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY FUNCTION; RHINOVIRUS; RNA VIRUS INFECTION; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS DETECTION; VIRUS INFECTION; VIRUS PNEUMONIA; VIRUS REPLICATION;

EID: 0033693177     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702656     Document Type: Article

References (22)

1. European experience of bone marrow transplantation for severe combined immuno-deficiency
2. Combination therapy for post-bone marrow transplant pneumonitis
3. Primary immunodeficiency diseases: Report of a WHO scientific group
4. Treatment of parainfluenza type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid
5. Clinical experience with aerosolised immunoglobulin treatment of respiratory syncytial virus infection in infants
6. Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency
7. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency
8. The association of rhino-viruses with lower respiratory tract disease in hospitalized patients
9. Adenoviruses in the immunocompromised host
10. Intravenous ribavirin therapy for disseminated adenovirus infection
11. Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin
12. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
13. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation
14. An outbreak of respiratory syncytial virus in a bone marrow transplant center
15. Respiratory syncytial virus infection in adult BMT recipients: Effective therapy with short duration nebulised ribavirin
16. Respiratory virus infections in bone marrow transplant recipients: The European perspective
17. Parainfluenza virus respiratory infection after bone marrow transplantation
18. Topically administered immunoglobulin reduces respiratory syncytial virus shedding in owl monkeys
19. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small particle aerosol generator
20. Topical immunoglobulin is an effective therapy for P13 in a cotton rat model
21. Clinical experience of respiratory viral infections in children undergoing bone marrow transplantation for primary immunodeficiencies